Mirador Capital Partners LP - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mirador Capital Partners LP ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$744,000
+6.9%
17,084
+6.9%
0.18%
+24.8%
Q1 2022$696,000
+24.5%
15,985
+26.1%
0.14%
+19.5%
Q4 2021$559,000
+17.9%
12,672
+2.2%
0.12%
+9.3%
Q3 2021$474,000
-3.9%
12,395
+0.1%
0.11%
-3.6%
Q2 2021$493,000
+16.8%
12,380
+4.8%
0.11%
+3.7%
Q1 2021$422,000
-7.3%
11,815
-4.5%
0.11%
-13.6%
Q4 2020$455,000
-1.3%
12,371
+0.9%
0.12%
-13.2%
Q3 2020$461,000
-14.9%
12,258
-7.7%
0.14%
-29.1%
Q2 2020$542,000
-3.2%
13,281
+0.6%
0.20%
-13.2%
Q1 2020$560,000
-8.6%
13,205
+1.2%
0.23%
-5.3%
Q4 2019$613,000
+13.9%
13,043
+3.4%
0.25%
+2.9%
Q3 2019$538,000
+7.4%
12,609
+0.7%
0.24%
-2.8%
Q2 2019$501,000
+1.6%
12,521
+6.1%
0.25%
-7.5%
Q1 2019$493,000
+7.2%
11,800
-2.1%
0.27%
-6.0%
Q4 2018$460,000
-2.5%
12,048
+2.6%
0.28%
+22.9%
Q3 2018$472,000
-1.3%
11,743
-1.1%
0.23%
-11.2%
Q2 2018$478,000
+0.4%
11,8680.0%0.26%
-21.7%
Q1 2018$476,000
+87.4%
11,868
+66.0%
0.33%
+138.8%
Q4 2017$254,000
-10.6%
7,151
+3.1%
0.14%
-16.8%
Q3 2017$284,000
+1.1%
6,9360.0%0.17%
-2.9%
Q2 2017$281,000
-4.4%
6,936
-0.5%
0.17%
-19.6%
Q1 2017$294,000
+22.0%
6,973
+11.6%
0.21%
+10.9%
Q4 2016$241,000
-5.9%
6,250
+5.4%
0.19%
-14.2%
Q3 2016$256,000
-5.5%
5,929
-1.7%
0.22%
-17.3%
Q2 2016$271,000
+10.6%
6,029
-0.3%
0.27%0.0%
Q1 2016$245,0006,0500.27%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2018
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders